Provided by Tiger Fintech (Singapore) Pte. Ltd.

bluebird bio

4.00
-0.1100-2.68%
Post-market: 4.000.00000.00%19:59 EST
Volume:134.19K
Turnover:540.32K
Market Cap:38.89M
PE:-0.12
High:4.14
Open:4.06
Low:3.94
Close:4.11
Loading ...

Bluebird: Q2 Earnings Snapshot

Associated Press Finance
·
28 Sep 2024

bluebird bio Announces Completion of its Q2 2024 Form 10-Q Filing

Business Wire
·
28 Sep 2024

Pfizer's Strategy Looks Shakier After Sickle-Cell Disappointment -- Barrons.com

Dow Jones
·
26 Sep 2024

bluebird bio Is Maintained at Equal-Weight by Wells Fargo

Dow Jones
·
26 Sep 2024

Gene Therapy-Focused Bluebird Bio Restructures, Cuts Is Workforce By 25%, Seeks To Breakeven Next Year

Benzinga
·
25 Sep 2024

William Blair Reaffirms Their Hold Rating on Bluebird Bio (BLUE)

TIPRANKS
·
24 Sep 2024

bluebird bio Shares up 2.9% After Co to Cut 25% of Workforce as Part of Restructuring

THOMSON REUTERS
·
24 Sep 2024

Bluebird Bio to Reduce Workforce by 25% as Part of Restructuring

MT Newswires Live
·
24 Sep 2024

BUZZ-Bluebird bio gains after cutting 25% workforce to reduce costs

Reuters
·
24 Sep 2024

Bluebird bio to Cut 25% of Workforce in Restructuring

Dow Jones
·
24 Sep 2024

bluebird bio Shares up 2% Premarket, Co to Cut 25% of Workforce as Part of Restructuring

THOMSON REUTERS
·
24 Sep 2024

Bluebird bio to cut 25% of workforce as part of restructuring

Reuters
·
24 Sep 2024

BRIEF-Bluebird Bio Inc - As Result of Restructuring Will Incur Aggregate Charges Of About $3.7 Million In Cash Expenditures

Reuters
·
24 Sep 2024

bluebird bio: Restructuring Charges to Be Paid Out Over Multiple Weeks Through Fiscal Year Ending Dec 31 End

THOMSON REUTERS
·
24 Sep 2024

bluebird bio Inc - as Result of Restructuring, Estimates That It Will Incur Aggregate Charges of About $3.7 Mln in Cash Expenditures

THOMSON REUTERS
·
24 Sep 2024

BRIEF-Bluebird Bio Initiates Restructuring Intended To Optimize Cost Structure And Enable Quarterly Cash Flow Break-Even In The 2H25

Reuters
·
24 Sep 2024